Stock listing

NASDAQ:BIND BIND Therapeutics Inc Stock

Follow BIND Therapeutics Inc into a list and get an email when it puts out news.

Delisted NASDAQ:BIND no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BIND
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Where BIND Therapeutics Inc is listed

ListingExchangeCountryCurrency
NASDAQ:BIND · This page · DelistedNASDAQUnited StatesUSD
NASDAQ:BINDQ · DelistedNASDAQUnited StatesUSD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Charles A Rowland Jr
Other companies: Generation Bio Co (Director · Since at least Jun 11, 2020); Viking Therapeutics, Inc. (Director · Since at least Jul 1, 2017); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Nabriva Therapeutics AG (Director · Dec 30, 2016 – Aug 3, 2022 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 2, 2021 · Past); Vitae Pharmaceuticals Inc (Director · Sep 24, 2014 – Oct 25, 2016 · Past); Idenix Pharmaceuticals Inc (Director · Jun 6, 2013 – Aug 5, 2014 · Past); Viropharma Inc (VP, Chief Financial Officer · Oct 20, 2008 – Jan 24, 2014 · Past)
Director · May 28, 2014 – Jun 21, 2016 · Past
Robert Langer
Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); Ocata Therapeutics Inc (Director · Oct 4, 2011 – Feb 10, 2016 · Past)
Director · Sep 19, 2013 – Jun 21, 2016 · Past
Arthur Tzianabos
Other companies: Stoke Therapeutics, Inc. (Chairman · Since at least Jun 18, 2019); Q32 Bio Inc. (Director · Since at least Mar 27, 2018); Akouos Inc (Director · Jun 25, 2020 – Nov 30, 2022 · Past); Tempest Therapeutics, Inc. (President and CSO · Sep 3, 2013 – Dec 3, 2015 · Past)
Director · Oct 9, 2015 – Jun 21, 2016 · Past
Andrew Hirsch
Other companies: C4 Therapeutics, Inc. (President and Chief Executive Officer, Director · Since at least Oct 1, 2020); Editas Medicine, Inc. (Board Member · Since at least May 30, 2017); Agios Pharmaceuticals, Inc. (Chief Financial Officer · Sep 19, 2016 – Apr 22, 2020 · Past)
PRESIDENT & CEO, Director · Sep 19, 2013 – Jun 22, 2015 · Past
Hagop Youssoufian
Other companies: Progenics Pharmaceuticals Inc (Executive Vice President R&D · Aug 1, 2013 – Mar 3, 2014 · Past); Alaunos Therapeutics, Inc. (President of R&D and CMO · Jul 15, 2011 – Dec 31, 2012 · Past)
CHIEF MEDICAL OFFICER · Nov 1, 2014 – Mar 7, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about BIND Therapeutics Inc.